TPI1 has been proposed as a candidate oncogene, with its overexpression detected in several types of cancers, such as intrahepatic cholangiocarcinoma (ICC) [16], gastric [13], lung [17, 18], and prostate cancer [19]. Here, TPI1 is linked to intrahepatic cholangiocarcinoma.